(18)F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma

Immune checkpoint inhibitors (ICIs) are now commonly used to treat patients with metastatic malignant melanoma. Although concerns have been raised that the inflammatory response induced by ICIs may limit the ability of (18)F-FDG PET/CT to assess tumor response, systematic analyses on the use of (18)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Ito, Kimiteru, Teng, Rebecca, Schöder, Heiko, Humm, John L., Ni, Ai, Michaud, Laure, Nakajima, Reiko, Yamashita, Rikiya, Wolchok, Jedd D., Weber, Wolfgang A.
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2019
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424231/
https://ncbi.nlm.nih.gov/pubmed/30413661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.213652
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados